| Date Filed | Type | Description |
| 01/07/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 12/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/13/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/13/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/13/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/13/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/13/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/13/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 12/13/2019 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 12/10/2019 |
8-K
| Quarterly results |
| 11/14/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 11/12/2019 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 11/01/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – FCSC, PRTO, ARTX, ROAN |
| 10/28/2019 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 10/11/2019 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 09/26/2019 |
8-K/A
| Submission of Matters to a Vote of Security Holders |
| 09/25/2019 |
SC 13G
| Klein Roger M. reports a 6.9% stake in Fibrocell Science, Inc. |
| 09/23/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – UCFC, SEMG, ALDR, FCSC |
| 09/19/2019 |
GN
| SEMG, PVTL, FCSC and AVDR SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts |
| 09/17/2019 |
SC 13D/A
| KIRK RANDAL J has filed a Schedule 13D for FIBROCELL SCIENCE, INC. |
| 09/16/2019 |
GN
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Fibrocell Science, Inc. to Castle Creek Pharmaceutical Holdings, Inc. is Fair to Shareholders |
| 09/13/2019 |
8-K
| Quarterly results |
| 09/13/2019 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
|